School of Biomedical Sciences

Dr Ellen Gillespie

Postdoctoral Research Fellow
Frazer Institute
View researcher profile

Ellen successfully completed her Honours research with the Ruitenberg Lab in 2017, and then returned to the lab, which studies Neurotrauma, in 2018 to begin her PhD. Her work focusses on investigating the mechanism of action of a therapeutic called IVIG (intravenous immunoglobulin), and she is specifically aiming to understand how IVIG works to improve recovery from acute spinal cord injury.

Publications

Journal Articles (3)

Journal Articles

Gillespie, Ellen R. and Ruitenberg, Marc J. (2022). Neuroinflammation after SCI: Current insights and therapeutic potential of intravenous immunoglobulin. Journal of Neurotrauma, 39 (3-4), 320-332. doi: 10.1089/neu.2019.6952
Willis, Emily F., MacDonald, Kelli P. A., Nguyen, Quan H., Garrido, Adahir Labrador, Gillespie, Ellen R., Harley, Samuel B. R., Bartlett, Perry F., Schroder, Wayne A., Yates, Abi G., Anthony, Daniel C., Rose-John, Stefan, Ruitenberg, Marc J. and Vukovic, Jana (2020). Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. Cell, 180 (5), 833-846.e16. doi: 10.1016/j.cell.2020.02.013
Brennan, Faith H., Jogia, Trisha, Gillespie, Ellen R., Blomster, Linda V., Li, Xaria X., Nowlan, Bianca, Williams, Gail M., Jacobson, Esther, Osborne, Geoff W., Meunier, Frederic A., Taylor, Stephen M., Campbell, Kate E., MacDonald, Kelli P.A., Levesque, Jean-Pierre, Woodruff, Trent M. and Ruitenberg, Marc J. (2019). Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2. JCI Insight, 4 (9) e98254. doi: 10.1172/jci.insight.98254